![The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9fe9b0551ba8982cad417e64a1fe8413f9bd5c5/2-Table1-1.png)
The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3-1024x807.jpg)
Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net
Diagnostic significance of the tumour markers CEA, CA 15–3 and CA 125 in malignant effusions in breast cancer
![Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2015.8/MediaObjects/41416_2015_Article_BFbjc20158_Fig1_HTML.jpg)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer
![CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020) CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)](https://jnccn.org/view/journals/jnccn/18/3.5/full-jnccn20197391t1.jpg)
CLO20-029: The Prognostic and Predictive Significance of Joint İnvestigation of Tumor Marker CA 15-3 and Vitamin D in Breast Cancer Patients in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3.5 (2020)
![PDF] The potential role of preoperative serum cancer antigen CA 15-3 in the prognosis of breast cancer | Semantic Scholar PDF] The potential role of preoperative serum cancer antigen CA 15-3 in the prognosis of breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f8544e83f2b934cf70cdbc3846189a42ada513fb/2-Table1-1.png)
PDF] The potential role of preoperative serum cancer antigen CA 15-3 in the prognosis of breast cancer | Semantic Scholar
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t1.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b9a47261-1988-4af7-85b1-b8402d5beaf5/gr1.jpg)
The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15-3, and CA 72-4 antigens) in patients with a pelvic mass - American Journal of Obstetrics & Gynecology
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig3_HTML.jpg)